Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating A Novel Strategy: The Synergy IOL Mixed and Matched With the Symfony With Intelilight

NCT05604781 is registered in ClinicalTrials.gov with Center For Sight as lead sponsor.

NCT NCT05604781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05604781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating A Novel Strategy: The Synergy IOL Mixed and Matched With the Symfony With Intelilight
Lead sponsor
Center For Sight
Phase
Observational
Overall status
Completed
Start date
October 17, 2022
Completion date
May 16, 2023
Enrollment
41 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bilateral cataract, presbyopia